Mercy Oburu, Collymore to steer National Cancer Institute

Citizen TV digital content manager Mercy Susan Oburu. She has been appointed to the board of National Cancer Institute.

Citizen TV digital content manager Mercy Oburu has been appointed to the board of National Cancer Institute.

Mercy, a breast cancer survivor, was appointed by Health Cabinet Secretary Sicily Kariuki to serve on the board for three years with effect from May 6. Safaricom CEO Bob Collymore, another cancer survivor, was also named to the board alongside David Makumi and Evangeline Njiru.

“In exercise of the powers conferred by section 6 (2) of the Cancer Prevention and Control Act, 2012, the Cabinet Secretary for Health appoints David Makumi, Mercy Oburu, Bob Collymore and Evangeline Njiru to be members of the Board of the National Cancer Institute, for a period of three (3) years, with effect from the 6th May, 2019,” a Kenya Gazette notice by the CS read.

Mercy is also a director of the Africa Cancer Foundation. She holds an MBA in Strategic Management from Moi University and Bachelor’s degree from Daystar University. She previously worked in various capacities at the Kenya Television Network (KTN). Mercy is also trained in Women in Management, investigative reporting, and creative thinking and problem solving.

In October 2016, she was retrenched alongside more than 100 other Royal Media Services (RMS) employees but media house’s owner recalled her barely a week later.

In 2018, Collymore took a nine-month leave to get treatment in London after being diagonised with Acute Myeloid Leukemia: a type of cancer that starts in the blood-forming cells of the bone marrow.

Makumi is the chairman, Kenya Network of Cancer Organisations and manager, cancer programme, Aga Khan University Hospital while Evangeline, a physician and oncologist, is a lecturer at  Moi University’s School of Medicine.

 

Picture of BT Reporter
BT Reporter
editor [at] businesstoday.co.ke

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Safaricom CEO Peter Ndegwa has revealed that the telco had the highest internet traffic during the UEFA European Football Championship (Euro) finals

South Africa has emerged as a crucial country for clinical trials in AstraZeneca’s global operations, playing a pivotal role in advancing medical

Safaricom’s impact on society grew 16 times in the six-month period ending September 30, 2024, the group CEO Peter Ndegwa has revealed.

Safaricom (NSE: SCOM) PLC has announced Ksh28.1 Billion in net income attributable to equity holders for the six months ended September 30th